Stay updated on Preop Pembrolizumab in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Preop Pembrolizumab in Colorectal Cancer Clinical Trial page.

Latest updates to the Preop Pembrolizumab in Colorectal Cancer Clinical Trial page
- CheckyesterdayChange DetectedAdditions include a site-wide government funding notice and a revision update (v3.4.1); the deletion removes the previous revision (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check8 days agoChange DetectedShow glossary toggle was added and new metadata labels Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0 were introduced, while Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 labels were removed.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page shows a minor revision update: Revision v3.3.4 was added and Revision v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedThe study record shows termination and results posted on 2025-12-31, and adds detailed objectives and perioperative treatment plans for pembrolizumab plus vactosertib in colorectal cancer with resectable liver metastases.SummaryDifference4%

- Check44 days agoChange DetectedLocations now include California; the California Locations subsection and the HHS Vulnerability Disclosure link were removed, and the revision was updated to v3.3.3.SummaryDifference0.2%

- Check73 days agoChange DetectedRevision: v3.3.2 was added and revision: v3.2.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Preop Pembrolizumab in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Preop Pembrolizumab in Colorectal Cancer Clinical Trial page.